Path Traversal in Cisco Duo Device Health Application

CVE-2023-20229

A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.

Vulnerability class: Path Traversal (Directory Traversal)

EPSS: 0.004 (31.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.1 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H.

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2023-20229?
CVE-2023-20229 is a high-severity vulnerability in Cisco Duo Device Health Application, classified under Path Traversal. CVSS score: 7.1/10. Published 2023-08-16.
How severe is CVE-2023-20229?
High severity. CVSS v3 base score is 7.1 out of 10.